Prevalence of Vitamin D Deficiency Among Perinatally HIV-infected Thai Adolescents Receiving Antiretroviral Therapy

and ‡Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
The Pediatric Infectious Disease Journal (Impact Factor: 2.72). 11/2013; 32(11):1237-9. DOI: 10.1097/INF.0b013e31829e7a5c
Source: PubMed


We assessed the prevalence of vitamin D deficiency among 101 perinatally HIV-infected Thai adolescents receiving antiretroviral therapy. Median age was 14.3 (interquartile range 13.0-15.7) years, and 90% had a HIV RNA <50 copies/mL. The median (interquartile range) 25-hydroxyvitamin D (25-OHD) level was 24.8 (6.9-46.9) ng/mL; 25 (24.7%) had vitamin D deficiency (25-OHD <20 ng/mL) and 47 (46.5%) had insufficiency (25-OHD 20-30 ng/mL). Adolescents with vitamin D deficiency had significantly higher parathyroid hormone levels (54.9 vs. 40.2 pg/mL, P < 0.007). No associations between vitamin D deficiency and body mass index, bone mineral density, efavirenz use, HIV RNA, CD4 or self-reported sunlight exposure were observed.

1 Follower
13 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although debated in the literature, vitamin D has been purported to impact various extraskeletal diseases, including infectious diseases. Research on this vitamin, as it relates to human immunodeficiency virus (HIV) infection, for example, is particularly prolific and is the focus of this review. Risk factors in this context for suboptimal vitamin D nutritional status, represented by 25-hydroxyvitamin D (25(OH)D) levels, include darker phototype, northern geographic residence, combined antiretroviral therapy (ART), metabolic syndrome, exiguous vitamin D intake, and advanced HIV infection. Although a prospective observational study has linked deficiency of this vitamin to decreasing bone mineral density (BMD), cardiovascular disease, opportunistic infections, HIV progression, and mortality, lack of randomized data prohibits firm conclusions on causation. However, on the basis of the evidence, all HIV patients should consume at least 600-800 international units (IU) of vitamin D daily, unless there are compelling circumstances that call for greater intake. Furthermore, clinicians should consider screening for deficiency in those at risk.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The availability of highly potent antiretroviral treatment during the last decades has transformed human immunodeficiency virus (HIV) infection into a chronic disease. Children that were diagnosed during the first months or years of life and received treatment, are living longer and better and are presently reaching adolescence and adulthood. Perinatally HIV-infected adolescents (PHIV) and young adults may present specific clinical, behavior and social characteristics and demands. We have performed a literature review about different aspects that have to be considered in the care and follow-up of PHIV. The search included papers in the MEDLINE database via PubMed, located using the keywords "perinatally HIV-infected" AND "adolescents". Only articles published in English or Portuguese from 2003 to 2014 were selected. The types of articles included original research, systematic reviews, and quantitative or qualitative studies; case reports and case series were excluded. Results are presented in the following topics: "Puberal development and sexual maturation", "Growth in weight and height", "Bone metabolism during adolescence", "Metabolic complications", "Brain development, cognition and mental health", "Reproductive health", "Viral drug resistance" and "Transition to adult outpatient care". We hope that this review will support the work of pediatricians, clinicians and infectious diseases specialists that are receiving these subjects to continue treatment.
    08/2015; 4(3):277-84. DOI:10.5501/wjv.v4.i3.277
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There are limited data regarding the prevalence and risk factors relating to hypovitaminosis D in children of Thailand, a tropical country with abundant sunlight. The objective of this study was to assess the prevalence of hypovitaminosis D and examine factors associated with hypovitaminosis D in school-aged children in Bangkok, Thailand - a centrally located capital city. This cross-sectional study evaluated 159 healthy children (33.3% boys and 66.7% girls), aged 6 to 12 years, in Bangkok, Thailand (located at 13.45°N). Fasting plasma samples were examined for total 25-hydroxyvitamin D [25(OH)D] using electrochemiluminescence immunoassay. Demographic characteristics (age, sex, household income), past medical history (birth weight, allergic diseases, hospitalization), amount of sun exposure, anthropometric data, and selected biochemical tests were used to investigate for factors associated with hypovitaminosis D. Overall, the mean ± SD level of plasma 25(OH)D was 64.0 ± 15.1 nmol/L. Hypovitaminosis D (<75 nmol/L) was presented in 79.2% of subjects. Of these, the prevalence of vitamin D insufficiency and vitamin D deficiency were 59.7% and 19.5%, respectively. In univariate analysis, children with hypovitaminosis D (<75 nmol/L) had a higher mean body mass index (BMI) percentile than the vitamin D-sufficient group (56.7 ± 33.9 vs. 42.6 ± 36.0; P-value = 0.04). Plasma PTH levels in the children with hypovitaminosis D were significantly higher than in the children with normal levels of vitamin D (4.34 ± 1.38 vs 3.78 ± 1.25 pmol/L; P-value = 0.04). In multivariate analysis, high BMI percentile and high PTH concentration were the parameters associated with 25(OH)D level < 75 nmol/L. The prevalence of hypovitaminosis D in healthy Thai children is very high, despite their exposure to sunlight, and that prevalence increases in children with a high BMI percentile. As a result, a formal recommendation for vitamin D supplementation in Thai children should be considered.
    BMC Public Health 12/2015; 15(1):1588. DOI:10.1186/s12889-015-1588-6 · 2.26 Impact Factor